Additional Information

Description

Medroxyprogesterone acetate 150 mg/mL is a long-acting progestin used primarily for contraception and hormone replacement therapy. Medroxyprogesterone is typically administered intramuscularly and is indicated for the prevention of pregnancy and the management of certain gynecological conditions such as endometriosis and abnormal uterine bleeding.

This injectable medication is formulated to provide sustained action, with doses generally administered every 3 months. It works by inhibiting ovulation, thickening cervical mucus, and altering the endometrial lining, making it unsuitable for pregnancy. The drug is often chosen for its efficacy and ease of use, as it does not require daily administration like oral contraceptives.

Medroxyprogesterone 150 mg/mL is typically stored in single-dose vials. It is essential to ensure that the drug is injected by a healthcare provider to minimize the risk of improper administration. For patients with contraindications, such as those with a history of certain cancers or thromboembolic disorders, alternative forms of contraception should be considered.